Skip to content

Clinical trials

Multiple Myeloma trials in Saudi Arabia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Myeloma Country / region: Saudi Arabia Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20091
20191
20201
20211
20221
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Active, not recruiting2
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Janssen Research & Development, LLC2
AbbVie1
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company1
King Faisal Specialist Hospital & Research Center1
Novartis Pharmaceuticals1
SWOG Cancer Research Network1
Sanofi1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Myeloma8
Recurrence2
Breast Neoplasms1
Breast Neoplasms, Male1
Carcinoma, Non-Small-Cell Lung1
Lung Neoplasms1
Neoplasm Metastasis1
Neoplasms, Plasma Cell1
Prostatic Neoplasms1
Small Cell Lung Carcinoma1

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.